{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Clinical trial", "Constipation", "Digestion", "Gastrointestinal function", "Herbal treatment"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "29554961", "DateCompleted": {"Year": "2018", "Month": "04", "Day": "12"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "14"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "03", "Day": "20"}], "Language": ["eng"], "ELocationID": ["98", "10.1186/s12906-018-2168-y"], "Journal": {"ISSN": "1472-6882", "JournalIssue": {"Volume": "18", "Issue": "1", "PubDate": {"Year": "2018", "Month": "Mar", "Day": "20"}}, "Title": "BMC complementary and alternative medicine", "ISOAbbreviation": "BMC Complement Altern Med"}, "ArticleTitle": "A poly-herbal blend (Herbagut\u00ae) on adults presenting with gastrointestinal complaints: a randomised, double-blind, placebo-controlled study.", "Pagination": {"StartPage": "98", "MedlinePgn": "98"}, "Abstract": {"AbstractText": ["To evaluate the efficacy and tolerability of a poly-herbal formulation, Herbagut, for the treatment of gastrointestinal symptoms and its effect on quality of life parameters in patients presenting with self-reported, unsatisfactory bowel habits.", "This was a randomised, double-blind, placebo-controlled trial. Fifty adults with self-reported unsatisfactory bowel habits, primarily characterised by chronic constipation were randomly allocated to take Herbagut or a matching placebo for 28\u00a0days. Efficacy of gastrointestinal changes was measured by the completion of a patient daily diary evaluating changes in stool type (Bristol Stool Form Scale), ease of bowel movements, and feeling of complete evacuation; and the Gastrointestinal Symptom Rating Scale (GSRS). Changes in quality of life were also examined using the World Health Organization Quality of Life - abbreviated version (WHOQOL-BREF), and the Patient Assessment of Constipation-Quality of Life (PAC-QOL).", "All participants completed the 28-day trial with no adverse events reported. Compared to the placebo, weekly bowel movements increased over time (p\u2009<\u2009.001), as did self-reported, normal bowel motions (76% vs 4%; p\u2009<\u2009.001). Self-reported incomplete evacuation was also lower in the Herbagut group compared to placebo (24% vs 76%; p\u2009=\u2009<.001). GSRS domain ratings for abdominal pain, constipation, diarrhoea, indigestion, and reflux also decreased significantly in people taking Herbagut compared to placebo (p\u2009<\u2009.001, for all domains). Moreover, quality of life significantly improved in the Herbagut group compared to placebo as indicated by significantly greater improvement in WHOQOL-BREF domain ratings for overall quality of life, social relations, environmental health, psychological health, and physical health (p\u2009<\u2009.001, for all domains); and PAC-QOL domain ratings for physical discomfort, psychosocial discomfort, worries and concerns, and life satisfaction (p\u2009<\u2009.001, for all domains). The changes were considered clinically meaningful as evidenced by their large effect sizes.", "Herbagut ingestion over a 28-day period resulted in improvements in several gastrointestinal symptoms and overall quality of life. Further investigation utilising larger sample sizes and diverse clinical and cultural populations are needed.", "Clinical Trials Registry- India /2016/11/007479 . Registered 24 April 2015 (retrospectively registered)."]}, "AuthorList": [{"Identifier": ["0000-0002-6409-7839"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Psychology and Exercise Science, Murdoch University, Perth, WA, 6150, Australia. a.lopresti@murdoch.edu.au."}], "LastName": "Lopresti", "ForeName": "Adrian L", "Initials": "AL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Samvedna Hospital, B-27 88G, Ravindrapuri, New Colony, Varanasi, U.P, 221005, India."}], "LastName": "Gupta", "ForeName": "Hemant", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Southern Cross University, Military Road, East Lismore, NSW, 2480, Australia."}], "LastName": "Smith", "ForeName": "Stephen J", "Initials": "SJ"}], "PublicationTypeList": ["Journal Article", "Randomized Controlled Trial"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "BMC Complement Altern Med", "NlmUniqueID": "101088661", "ISSNLinking": "1472-6882"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": ["drug therapy", "physiopathology"], "DescriptorName": "Constipation"}, {"QualifierName": ["drug effects"], "DescriptorName": "Defecation"}, {"QualifierName": [], "DescriptorName": "Double-Blind Method"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["drug effects", "physiopathology"], "DescriptorName": "Gastrointestinal Tract"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "India"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Quality of Life"}], "CoiStatement": "ETHICS APPROVAL AND CONSENT TO PARTICIPATE: The study protocol was approved by \u2018Nagpur Independent Ethics Committee\u2019 and all participants provided informed consent. CONSENT FOR PUBLICATION: Not applicable. COMPETING INTERESTS: This study was independently managed by the principal investigator, Dr Hemant Gupta, who declares no competing interests. Dr Adrian Lopresti has received study funding from Arjuna Natural Extracts Ltd in the past for previously completed, unrelated studies. Mr Stephen Smith declares no competing interests. PUBLISHER\u2019S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Drossman DA. Functional gastrointestinal disorders: history, pathophysiology, clinical features and Rome IV. Gastroenterology. 150(6):1262\u2013279.", "ArticleIdList": ["27144617"]}, {"Citation": "Peery AF, Dellon ES, Lund J, Crockett SD, McGowan CE, Bulsiewicz WJ, Gangarosa LM, Thiny MT, Stizenberg K, Morgan DR, et al. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology. 2012;143(5):1179\u20131187. doi: 10.1053/j.gastro.2012.08.002.", "ArticleIdList": ["10.1053/j.gastro.2012.08.002", "PMC3480553", "22885331"]}, {"Citation": "Koloski NA, Talley NJ, Boyce PM. The impact of functional gastrointestinal disorders on quality of life. Am J Gastroenterol. 2000;95(1):67\u201371. doi: 10.1111/j.1572-0241.2000.01735.x.", "ArticleIdList": ["10.1111/j.1572-0241.2000.01735.x", "10638561"]}, {"Citation": "Addolorato G, Mirijello A, D'Angelo C, Leggio L, Ferrulli A, Abenavoli L, Vonghia L, Cardone S, Leso V, Cossari A, et al. State and trait anxiety and depression in patients affected by gastrointestinal diseases: psychometric evaluation of 1641 patients referred to an internal medicine outpatient setting. Int J Clin Pract. 2008;62(7):1063\u20131069. doi: 10.1111/j.1742-1241.2008.01763.x.", "ArticleIdList": ["10.1111/j.1742-1241.2008.01763.x", "18422970"]}, {"Citation": "Shah E, Rezaie A, Riddle M, Pimentel M. Psychological disorders in gastrointestinal disease: epiphenomenon, cause or consequence? Ann Gastroenterol. 2014;27(3):224\u2013230.", "ArticleIdList": ["PMC4073018", "24974805"]}, {"Citation": "Alander T, Svardsudd K, Agreus L. Functional gastrointestinal disorder is associated with increased non-gastrointestinal healthcare consumption in the general population. Int J Clin Pract. 2008;62(2):234\u2013240. doi: 10.1111/j.1742-1241.2007.01549.x.", "ArticleIdList": ["10.1111/j.1742-1241.2007.01549.x", "PMC2657998", "18021207"]}, {"Citation": "Sanchez MI, Bercik P. Epidemiology and burden of chronic constipation. Can J Gastroenterol. 2011;25(Suppl B):11B\u201315B. doi: 10.1155/2011/974573.", "ArticleIdList": ["10.1155/2011/974573", "PMC3206560", "22114752"]}, {"Citation": "Chang JY, Locke GR, 3rd, McNally MA, Halder SL, Schleck CD, Zinsmeister AR, Talley NJ. Impact of functional gastrointestinal disorders on survival in the community. Am J Gastroenterol. 2010;105(4):822\u2013832. doi: 10.1038/ajg.2010.40.", "ArticleIdList": ["10.1038/ajg.2010.40", "PMC2887253", "20160713"]}, {"Citation": "Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006;130(5):1377\u20131390. doi: 10.1053/j.gastro.2006.03.008.", "ArticleIdList": ["10.1053/j.gastro.2006.03.008", "16678553"]}, {"Citation": "Mearin F, Ciriza C, Minguez M, Rey E, Mascort JJ, Pena E, Canones P, Judez J. Clinical practice guideline: irritable bowel syndrome with constipation and functional constipation in the adult. Rev Esp Enferm Dig. 2016;108(6):332\u2013363.", "ArticleIdList": ["27230827"]}, {"Citation": "Herz MJ, Kahan E, Zalevski S, Aframian R, Kuznitz D, Reichman S. Constipation: a different entity for patients and doctors. Fam Pract. 1996;13(2):156\u2013159. doi: 10.1093/fampra/13.2.156.", "ArticleIdList": ["10.1093/fampra/13.2.156", "8732327"]}, {"Citation": "Campbell AJ, Busby WJ, Horwath CC. Factors associated with constipation in a community based sample of people aged 70 years and over. J Epidemiol Community Health. 1993;47(1):23\u201326. doi: 10.1136/jech.47.1.23.", "ArticleIdList": ["10.1136/jech.47.1.23", "PMC1059704", "8382251"]}, {"Citation": "Chang JY, Locke GR, Schleck CD, Zinsmeister AR, Talley NJ. Risk factors for chronic constipation and a possible role of analgesics. Neurogastroenterol Motil. 2007;19(11):905\u2013911. doi: 10.1111/j.1365-2982.2007.00974.x.", "ArticleIdList": ["10.1111/j.1365-2982.2007.00974.x", "17988275"]}, {"Citation": "Dossett ML, Davis RB, Lembo AJ, Yeh GY. Complementary and alternative medicine use by US adults with gastrointestinal conditions: results from the 2012 National Health Interview Survey. Am J Gastroenterol. 2014;109(11):1705\u20131711. doi: 10.1038/ajg.2014.108.", "ArticleIdList": ["10.1038/ajg.2014.108", "PMC4304651", "25001257"]}, {"Citation": "Hung A, Kang N, Bollom A, Wolf JL, Lembo A. Complementary and alternative medicine use is prevalent among patients with gastrointestinal diseases. Dig Dis Sci. 2015;60(7):1883\u20131888. doi: 10.1007/s10620-014-3498-3.", "ArticleIdList": ["10.1007/s10620-014-3498-3", "25556585"]}, {"Citation": "Farzaei MH, Bahramsoltani R, Abdolghaffari AH, Sodagari HR, Esfahani SA, Rezaei N. A mechanistic review on plant-derived natural compounds as dietary supplements for prevention of inflammatory bowel disease. Expert Rev Gastroenterol Hepatol. 2016;10(6):745\u2013758. doi: 10.1586/17474124.2016.1145546.", "ArticleIdList": ["10.1586/17474124.2016.1145546", "26799847"]}, {"Citation": "Farzaei MH, Bahramsoltani R, Abdollahi M, Rahimi R. The role of visceral hypersensitivity in irritable bowel syndrome: pharmacological targets and novel treatments. J Neurogastroenterol Motil. 2016;22(4):558\u2013574. doi: 10.5056/jnm16001.", "ArticleIdList": ["10.5056/jnm16001", "PMC5056566", "27431236"]}, {"Citation": "O'Donnell LJ, Virjee J, Heaton KW. Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit rate. BMJ. 1990;300(6722):439\u2013440. doi: 10.1136/bmj.300.6722.439.", "ArticleIdList": ["10.1136/bmj.300.6722.439", "PMC1662249", "2107897"]}, {"Citation": "Kulich KR, Madisch A, Pacini F, Pique JM, Regula J, Van Rensburg CJ, Ujszaszy L, Carlsson J, Halling K, Wiklund IK. Reliability and validity of the gastrointestinal symptom rating scale (GSRS) and quality of life in reflux and dyspepsia (QOLRAD) questionnaire in dyspepsia: a six-country study. Health Qual Life Outcomes. 2008;6:12. doi: 10.1186/1477-7525-6-12.", "ArticleIdList": ["10.1186/1477-7525-6-12", "PMC2276197", "18237386"]}, {"Citation": "World Health Organization Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychol Med. 1998;28(3):551\u2013558. doi: 10.1017/S0033291798006667.", "ArticleIdList": ["10.1017/S0033291798006667", "9626712"]}, {"Citation": "Skevington SM, Lotfy M, O'Connell KA, Group W The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Qual Life Res. 2004;13(2):299\u2013310. doi: 10.1023/B:QURE.0000018486.91360.00.", "ArticleIdList": ["10.1023/B:QURE.0000018486.91360.00", "15085902"]}, {"Citation": "Marquis P, De La Loge C, Dubois D, McDermott A, Chassany O. Development and validation of the patient assessment of constipation quality of life questionnaire. Scand J Gastroenterol. 2005;40(5):540\u2013551. doi: 10.1080/00365520510012208.", "ArticleIdList": ["10.1080/00365520510012208", "16036506"]}, {"Citation": "Dulbecco P, Savarino V. Therapeutic potential of curcumin in digestive diseases. World J Gastroenterol. 2013;19(48):9256\u20139270. doi: 10.3748/wjg.v19.i48.9256.", "ArticleIdList": ["10.3748/wjg.v19.i48.9256", "PMC3882399", "24409053"]}, {"Citation": "Hanai H, Iida T, Takeuchi K, Watanabe F, Maruyama Y, Andoh A, Tsujikawa T, Fujiyama Y, Mitsuyama K, Sata M, et al. Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol. 2006;4(12):1502\u20131506. doi: 10.1016/j.cgh.2006.08.008.", "ArticleIdList": ["10.1016/j.cgh.2006.08.008", "17101300"]}, {"Citation": "Feng W, Wang H, Zhang P, Gao C, Tao J, Ge Z, Zhu D, Bi Y. Modulation of gut microbiota contributes to curcumin-mediated attenuation of hepatic steatosis in rats. Biochim Biophys Acta. 2017;1861(7):1801\u20131812. doi: 10.1016/j.bbagen.2017.03.017.", "ArticleIdList": ["10.1016/j.bbagen.2017.03.017", "28341485"]}, {"Citation": "Gull I, Saeed M, Shaukat H, Aslam SM, Samra ZQ, Athar AM. Inhibitory effect of Allium sativum and Zingiber officinale extracts on clinically important drug resistant pathogenic bacteria. Ann Clin Microbiol Antimicrob. 2012;11:8. doi: 10.1186/1476-0711-11-8.", "ArticleIdList": ["10.1186/1476-0711-11-8", "PMC3418209", "22540232"]}, {"Citation": "Viljoen E, Visser J, Koen N, Musekiwa A. A systematic review and meta-analysis of the effect and safety of ginger in the treatment of pregnancy-associated nausea and vomiting. Nutr J. 2014;13:20. doi: 10.1186/1475-2891-13-20.", "ArticleIdList": ["10.1186/1475-2891-13-20", "PMC3995184", "24642205"]}, {"Citation": "Hu ML, Rayner CK, Wu KL, Chuah SK, Tai WC, Chou YP, Chiu YC, Chiu KW, Hu TH. Effect of ginger on gastric motility and symptoms of functional dyspepsia. World J Gastroenterol. 2011;17(1):105\u2013110. doi: 10.3748/wjg.v17.i1.105.", "ArticleIdList": ["10.3748/wjg.v17.i1.105", "PMC3016669", "21218090"]}, {"Citation": "Butt MS, Pasha I, Sultan MT, Randhawa MA, Saeed F, Ahmed W. Black pepper and health claims: a comprehensive treatise. Crit Rev Food Sci Nutr. 2013;53(9):875\u2013886. doi: 10.1080/10408398.2011.571799.", "ArticleIdList": ["10.1080/10408398.2011.571799", "23768180"]}, {"Citation": "Mukherjee A, Sengupta S, Ray L, Sengupta S. Evaluation of Tinospora cordifolia amylase as a commercial digestive enzyme of plant origin. Journal of Herbs, Spices & Medicinal Plants. 2012;18(1):58\u201376. doi: 10.1080/10496475.2011.649515.", "ArticleIdList": ["10.1080/10496475.2011.649515"]}, {"Citation": "Bafna PA, Balaraman R. Anti-ulcer and anti-oxidant activity of pepticare, a herbomineral formulation. Phytomedicine. 2005;12(4):264\u2013270. doi: 10.1016/j.phymed.2003.12.009.", "ArticleIdList": ["10.1016/j.phymed.2003.12.009", "15898703"]}, {"Citation": "Nagappan T, Ramasamy P, Wahid ME, Segaran TC, Vairappan CS. Biological activity of carbazole alkaloids and essential oil of Murraya koenigii against antibiotic resistant microbes and cancer cell lines. Molecules. 2011;16(11):9651\u20139664. doi: 10.3390/molecules16119651.", "ArticleIdList": ["10.3390/molecules16119651", "PMC6264343", "22105714"]}, {"Citation": "Laxmi A, Siddhartha S, Archana M. Antimicrobial screening of methanol and aqueous extracts of Swertia chirata. Int J Pharm Pharm Sci. 2011;3:142\u2013146."}, {"Citation": "Santino A, Scarano A, Santis S, Benedictis M, Giovinazzo G, Chieppa M. Gut microbiota modulation and anti-inflammatory properties of dietary polyphenols in IBD: new and consolidated perspectives. Curr Pharm Des. 2017;23(16):2344\u20132351. doi: 10.2174/1381612823666170207145420.", "ArticleIdList": ["10.2174/1381612823666170207145420", "28176667"]}, {"Citation": "Leong RW, Chan FK. Drug-induced side effects affecting the gastrointestinal tract. Expert Opin Drug Saf. 2006;5(4):585\u2013592. doi: 10.1517/14740338.5.4.585.", "ArticleIdList": ["10.1517/14740338.5.4.585", "16774495"]}, {"Citation": "Siris ES, Fan CS, Yang X, Sajjan S, Sen SS, Modi A. Association between gastrointestinal events and compliance with osteoporosis therapy. Bone Rep. 2016;4:5\u201310. doi: 10.1016/j.bonr.2015.10.006.", "ArticleIdList": ["10.1016/j.bonr.2015.10.006", "PMC4926838", "28326336"]}, {"Citation": "Rieder R, Wisniewski PJ, Alderman BL, Campbell SC. Microbes and mental health: a review. Brain Behav Immun. 2017;66:9\u201317. doi: 10.1016/j.bbi.2017.01.016.", "ArticleIdList": ["10.1016/j.bbi.2017.01.016", "28131791"]}, {"Citation": "Hill JM, Bhattacharjee S, Pogue AI, Lukiw WJ. The gastrointestinal tract microbiome and potential link to Alzheimer's disease. Front Neurol. 2014;5:43. doi: 10.3389/fneur.2014.00043.", "ArticleIdList": ["10.3389/fneur.2014.00043", "PMC3983497", "24772103"]}, {"Citation": "Poirier AA, Aube B, Cote M, Morin N, Di Paolo T, Soulet D. Gastrointestinal dysfunctions in Parkinson's disease: symptoms and treatments. Parkinsons Dis. 2016;2016:6762528.", "ArticleIdList": ["PMC5168460", "28050310"]}, {"Citation": "Sanz Y, Olivares M, Moya-Perez A, Agostoni C. Understanding the role of gut microbiome in metabolic disease risk. Pediatr Res. 2015;77(1\u20132):236\u2013244. doi: 10.1038/pr.2014.170.", "ArticleIdList": ["10.1038/pr.2014.170", "25314581"]}, {"Citation": "Li WQ, Han JL, Chan AT, Qureshi AA. Psoriasis, psoriatic arthritis and increased risk of incident Crohn's disease in US women. Ann Rheum Dis. 2013;72(7):1200\u20131205. doi: 10.1136/annrheumdis-2012-202143.", "ArticleIdList": ["10.1136/annrheumdis-2012-202143", "PMC3547138", "22941766"]}, {"Citation": "Caffarelli C, Cavagni G, Deriu FM, Zanotti P, Atherton DJ. Gastrointestinal symptoms in atopic eczema. Arch Dis Child. 1998;78(3):230\u2013234. doi: 10.1136/adc.78.3.230.", "ArticleIdList": ["10.1136/adc.78.3.230", "PMC1717511", "9613352"]}, {"Citation": "Huang R, Wang K, Hu J. Effect of probiotics on depression: a systematic review and meta-analysis of randomized controlled trials. Nutrients. 2016;8(8):483.", "ArticleIdList": ["PMC4997396", "27509521"]}, {"Citation": "Wallace CJ, Milev R. The effects of probiotics on depressive symptoms in humans: a systematic review. Ann General Psychiatry. 2017;16:14. doi: 10.1186/s12991-017-0138-2.", "ArticleIdList": ["10.1186/s12991-017-0138-2", "PMC5319175", "28239408"]}, {"Citation": "Lopresti AL. Curcumin for neuropsychiatric disorders: a review of in vitro, animal and human studies. J Psychopharmacol. 2017;31(3):287\u2013302. doi: 10.1177/0269881116686883.", "ArticleIdList": ["10.1177/0269881116686883", "28135888"]}]}], "History": [{"Year": "2017", "Month": "6", "Day": "30"}, {"Year": "2018", "Month": "3", "Day": "14"}, {"Year": "2018", "Month": "3", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "3", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "4", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "3", "Day": "20"}], "PublicationStatus": "epublish", "ArticleIdList": ["29554961", "PMC5859649", "10.1186/s12906-018-2168-y", "10.1186/s12906-018-2168-y"]}}]}